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Abstract Custom-made mandibular advancement devices
are an effective treatment option for snoring, upper airway
resistance syndrome, and obstructive sleep apnea (OSA).
Evidence-based data indicates their efficacy, and interna-
tional sleep societies recommend oral appliance (OA)
therapy for patients with sleep-related breathing disorders.
The following position paper by the German Society of
Dental Sleep Medicine (DGZS) is to guide the interdisci-
plinary team (sleep physician and sleep disorder dentist) in
detail when to prescribe oral appliances. This position paper
supports the responsible use of OA as an effective treatment
option for patients with sleep-related breathing disorders.
The paper advises of proper indication regarding OSA
severity, body mass index (BMI), and dentition. It empha-
sizes the interdisciplinary approach of oral appliance
therapy and suggests treatment under the guidance of
dentists trained in dental sleep medicine.
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Introduction
Various options are available in the treatment of obstructive
sleep-related breathing disorders (SRBD):
– Continuous or bi-level positive airway pressure
(nCPAP/biPAP)
– Mandibular advancement devices (MADs)
– Surgical procedures
– Other procedures
The use of oral appliances in treating SRBD was first
described in 1982 [3]. The first findings, which document
the therapeutic effect of MADs, were presented in 1984 [8].
Of the many oral appliances designed for use in the
treatment of SRBD, mandibular advancement devices have
been the most intensely researched. Progress in the areas of
dentistry and appliance technology has lead to fundamental
modifications in the design of mandibular advancement
devices.
The clinical effectiveness of this treatment option has
been documented with varying degrees of evidence in
numerous studies. The clinical importance of this form of
therapy is constantly being reinforced by the gathering of
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Heilbronn, Germanyimproved data on the validity of this form of treatment. The
effectiveness of mandibular advancement devices in the
treatment of SRBD has been documented by the Cochrane
Collaboration as the highest level of scientific evidence [5].
The clinical analysis has been reviewed and revised twice
since Cochrane’s first evaluation in 2002 [6, 7]. The
German Society of Dental Sleep Medicine (DGZS) takes
this opportunity to issue its position with regard to this form
of therapy and to make recommendations.
The definition of mandibular advancement devices
in the treatment of SRBD
A system of laboratory fabricated custom-made adjustable
splints manufactured for the individual patient and adjusted to
fit the upper and lower jaws. These splints position the lower
jaw, tongue, and additional structures more anteriorly, and
increasetheocclusalvertical dimension,resulting inanopening
of the pharynx lumen, which reduces resistance in the airway
and mechanically keeps the airway open during sleep.
Guidelines and indication recommendations
from professional sleep-medicine societies
As early as 1995, the American Academy of Sleep
Medicine (AASM) published recommendations on the
indication and application of oral appliances in the
treatment of SRBD [1]. These were updated and stated
more precisely in 2005 [2]. In 2001, the German Society of
Pneumology (DGP) in co-operation with the German Sleep
Society (DGSM) published the “S2” guidelines on the
diagnosis and treatment of SRBD. These guidelines
envisaged the use of mandibular advancement devices as
a treatment option [4]. A new description of the significance
of mandibular advancement devices was formulated by the
“Task Force Apnea of the DGSM” in the year 2006 [9].
Based on scientific appraisals and international guide-
lines, the DGZS recommends the use of mandibular
advancement devices in the treatment of SRBD:
1. As an initial treatment for
– Primary snoring
– Upper airway resistance syndrome
– Mild to moderate obstructive sleep apnea [apnea
hypopnea index (AHI) up to about 25/h] with
minor clinical symptoms with a sufficient number
of retaining teeth and a body mass index (BMI) of
up to 30 kg/m
2
2. In cases of SRBD with an approximate AHI of over 25/h,
MADs can be used as an alternative after a previous
therapeutic trial with nCPAP.
3. Regardless of SRBD severity in patients with CPAP
failure and CPAP noncompliance.
4. A special dental, oral, and functional diagnosis is
necessary to check the dental requirements for long-
term use before prescribing MADs.
5. The procedure should take into account the various
interdisciplinary and intradisciplinary treatment flows,
particularly the preliminary medical diagnosis and the
subsequent medical follow-ups.
6. This service should be delivered by dentists who have
specialized training in the field of sleep medicine.
The DGZS supports the specialized training of dentists
and physicians in the field of dental sleep medicine.
Patients and referring physicians can find the addresses of
certified practitioners on the DGZS website at http://www.
dgzs.de.
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